Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

496 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial.
Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, Croce D. Restelli U, et al. Among authors: nappi c. Clinicoecon Outcomes Res. 2017 Mar 1;9:173-179. doi: 10.2147/CEOR.S127097. eCollection 2017. Clinicoecon Outcomes Res. 2017. PMID: 28280375 Free PMC article.
Update of the budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial.
Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, Croce D. Restelli U, et al. Among authors: nappi c. Clinicoecon Outcomes Res. 2017 Sep 27;9:569-571. doi: 10.2147/CEOR.S143377. eCollection 2017. Clinicoecon Outcomes Res. 2017. PMID: 29026324 Free PMC article. No abstract available.
Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada.
Weijers L, Baerwald C, Mennini FS, Rodríguez-Heredia JM, Bergman MJ, Choquette D, Herrmann KH, Attinà G, Nappi C, Merino SJ, Patel C, Mtibaa M, Foo J. Weijers L, et al. Among authors: nappi c. Rheumatol Int. 2017 Jul;37(7):1111-1123. doi: 10.1007/s00296-017-3739-9. Epub 2017 May 30. Rheumatol Int. 2017. PMID: 28560470 Free PMC article. Clinical Trial.
Cost-effectiveness analysis of the use of daclatasvir + sofosbuvir + ribavirin (16 weeks and 12 weeks) vs sofosbuvir + ribavirin (16 weeks and 24 weeks) for the treatment of cirrhotic patients affected with hepatitis C virus genotype 3 in Italy.
Restelli U, Alberti A, Lazzarin A, Bonfanti M, Nappi C, Croce D. Restelli U, et al. Among authors: nappi c. Eur J Health Econ. 2018 Jan;19(1):37-44. doi: 10.1007/s10198-016-0865-3. Epub 2016 Dec 22. Eur J Health Econ. 2018. PMID: 28008546
496 results